Metamizole-associated risks in decompensated hepatic cirrhosis-Reference-Cited by-同舟云学术

Metamizole-associated risks in decompensated hepatic cirrhosis

Published:2022-10-14 Issue: Volume: Page:
ISSN:1866-0452
Container-title:Deutsches Ärzteblatt international
language:
Short-container-title:

Author:

Schulte Benjamin,Tergast Tammo L.,Griemsmann Marie,Menti Denise,Deveci Neslihan,Kahlhöfer Julia,Dörge Petra,Hüffner Lucas,Kraft Anke R. M.,Behrendt Patrick,Wedemeyer Heiner,Cornberg Markus,Stichtenoth Dirk O.,Maasoumy Benjamin

Publisher

Deutscher Arzte-Verlag GmbH

Subject

General Medicine

Reference40 articles.

1. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69: 406–60.

2. Peng J, Hepgul N, Higginson IJ, Gao W: Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliat Med 2019; 33: 24–36.

3. Rakoski M, Goyal P, Spencer-Safier M, Weissman J, Mohr G, Volk M: Pain management in patients with cirrhosis. Clin Liver Dis (Hoboken) 2018; 11: 135–40.

4. Klinge M, Coppler T, Liebschutz JM, et al.: The assessment and management of pain in cirrhosis. Curr Hepatol Rep 2018; 17: 42–51.

5. Benson GD: Acetaminophen in chronic liver disease. Clin Pharmacol Ther 1983; 33: 95–101.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of metamizole to prevent kidney injury after renal-ischaemic reperfusion injury in Wistar rats;Annals of Medicine & Surgery;2024-01-12

2. Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis;Scientific Reports;2023-10-14

3. Clinical Guideline on Perioperative Management of Patients with Advanced Chronic Liver Disease;Life;2023-01-03